Latest filing published 27 Feb 2023 for 沃森生物, €3.5M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -53.2%Entry CN¥38.27 · Close at T+365 CN¥17.90
- -54.2%Entry CN¥38.70 · Close at T+365 CN¥17.74
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
广州盈沃企业管理合伙企业(有限合伙): trading record in brief
广州盈沃企业管理合伙企业(有限合伙) (chief executive) discloses dealings in 沃森生物 to SSE / SZSE (CSRC). Between 17 February 2023 and 27 February 2023, the trades on record add up to 2 filings.
The open-market record is one-sided, with 2 purchases worth €13.7M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 27 February 2023 with an open-market purchase (€3.5M) in 沃森生物. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Companies and markets linked to 广州盈沃企业管理合伙企业(有限合伙)
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 667,600 shares25.3% of flowA股XSHESZSE:173000006349769820Canonical exit: 28 May 2023 (T+90)
- 1,968,200 shares74.7% of flowA股XSHESZSE:173000006286409570Canonical exit: 18 May 2023 (T+90)
2 of 2 declarations